| Screening test |
= Diabetes |
Increased risk |
Normal |
| HbA1c | ≥ 6.5% | 5.7-6.4% | < 5.7% |
| Fasting BG | ≥ 126 mg/dL | 100-125 mg/dL | < 100 mg/dL |
| Random BG | ≥ 200 mg/dL | 140-199 mg/dL | < 140 mg/dL |
| Oral glucose tolerance (75 g, testing at 2 hrs) |
≥ 200 mg/dL | 140-199 mg/dL | < 140 mg/dL |
| Drug | Dose | Weight | Renal insuff. | Hypoglycemia | Side effects |
| Metformin | 500 - 1000 mg BID | - | No (lactic acidosis) | - | Start at QD to minimize GI distress |
|
Sulfonylurea |
↑ | OK | + | ||
| GLP-1 analog exenatide (Bydureon) |
|
↓ |
- | Appetite suppressant Possibly a/w pancreatitis |
|
| DPP-4 inhibitor sitagliptin (Januvia) |
- |
OK |
- |
||
| TZD (pioglitazone) Increase insulin sensitivity |
↑ | OK | - | Edema, CHF |
Diabetic ketoacidosis